Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 2
1976 1
1977 1
1978 2
1979 1
1980 1
1981 6
1982 11
1983 32
1984 61
1985 60
1986 60
1987 49
1988 117
1989 129
1990 185
1991 178
1992 245
1993 241
1994 225
1995 289
1996 322
1997 450
1998 411
1999 470
2000 490
2001 583
2002 789
2003 822
2004 884
2005 1010
2006 1025
2007 1119
2008 1091
2009 1146
2010 1205
2011 1324
2012 1413
2013 1547
2014 1604
2015 1626
2016 1766
2017 1801
2018 1625
2019 1532
2020 1684
2021 1967
2022 2089
2023 1565
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

32,321 results

Results by year

Filters applied: . Clear all
Page 1
Type II diabetes mellitus: a review on recent drug based therapeutics.
Padhi S, Nayak AK, Behera A. Padhi S, et al. Biomed Pharmacother. 2020 Nov;131:110708. doi: 10.1016/j.biopha.2020.110708. Epub 2020 Sep 11. Biomed Pharmacother. 2020. PMID: 32927252 Free article. Review.
Pathological changes such as nephropathy, retinopathy, and cardiovascular complications inevitably occur in the body with the progression of the disease. DM is mainly categorized into 2 sub-types, type I DM and type II DM. While type I DM is gen …
Pathological changes such as nephropathy, retinopathy, and cardiovascular complications inevitably occur in the body with the progression of …
Effects of probiotics on type II diabetes mellitus: a meta-analysis.
Tao YW, Gu YL, Mao XQ, Zhang L, Pei YF. Tao YW, et al. J Transl Med. 2020 Jan 17;18(1):30. doi: 10.1186/s12967-020-02213-2. J Transl Med. 2020. PMID: 31952517 Free PMC article. Review.
OBJECTIVE: The purpose of the present study was to evaluate the effectiveness of probiotics on type II diabetes mellitus (T2DM). METHODS: We performed a comprehensive search on PubMed, Web of Science, China National Knowledge Infrastructure, Chinese Sc …
OBJECTIVE: The purpose of the present study was to evaluate the effectiveness of probiotics on type II diabetes mell
The role of yoghurt consumption in the management of type II diabetes.
Yanni AE, Kartsioti K, Karathanos VT. Yanni AE, et al. Food Funct. 2020 Dec 1;11(12):10306-10316. doi: 10.1039/d0fo02297g. Epub 2020 Nov 19. Food Funct. 2020. PMID: 33211046 Review.
Enrichment of yoghurt with specific ingrdients beneficially affects the management of Type II Diabetes Mellitus (DMII). As far as the role of yoghurt in the management of DMII is concerned, the limited number of randomized clinical trials (RCTs) which …
Enrichment of yoghurt with specific ingrdients beneficially affects the management of Type II Diabetes Mellitus
Tirzepatide: First Approval.
Syed YY. Syed YY. Drugs. 2022 Jul;82(11):1213-1220. doi: 10.1007/s40265-022-01746-8. Drugs. 2022. PMID: 35830001 Review.
GIP also plays a role in nutrient and energy metabolism, while GLP-1 also delays gastric emptying, supresses appetite and improves satiety. Eli Lilly is developing tirzepatide for the treatment of type 2 diabetes mellitus (T2DM), obesity, cardiovascula …
GIP also plays a role in nutrient and energy metabolism, while GLP-1 also delays gastric emptying, supresses appetite and improves satiety. …
Role of Cellular Senescence in Type II Diabetes.
Narasimhan A, Flores RR, Robbins PD, Niedernhofer LJ. Narasimhan A, et al. Endocrinology. 2021 Oct 1;162(10):bqab136. doi: 10.1210/endocr/bqab136. Endocrinology. 2021. PMID: 34363464 Free PMC article. Review.
Senescent cells release a myriad of senescence-associated secretory phenotype factors that directly mediate pancreatic beta-cell dysfunction, adipose tissue dysfunction, and insulin resistance in peripheral tissues, which promote the onset of type II diabetes
Senescent cells release a myriad of senescence-associated secretory phenotype factors that directly mediate pancreatic beta-cell dysfunction …
Treatment of Diabetic Kidney Disease: Current and Future.
Yamazaki T, Mimura I, Tanaka T, Nangaku M. Yamazaki T, et al. Diabetes Metab J. 2021 Jan;45(1):11-26. doi: 10.4093/dmj.2020.0217. Epub 2021 Jan 22. Diabetes Metab J. 2021. PMID: 33508907 Free PMC article. Review.
However, only renin-angiotensin system inhibitor with multidisciplinary treatments is effective for DKD. In 2019, sodium-glucose cotransporter 2 (SGLT2) inhibitor showed efficacy against DKD in Canagliflozin and Renal Events in Diabetes with Established Nephropathy …
However, only renin-angiotensin system inhibitor with multidisciplinary treatments is effective for DKD. In 2019, sodium-glucose cotransport …
Clinically relevant experimental rodent models of diabetic foot ulcer.
Rai V, Moellmer R, Agrawal DK. Rai V, et al. Mol Cell Biochem. 2022 Apr;477(4):1239-1247. doi: 10.1007/s11010-022-04372-w. Epub 2022 Jan 28. Mol Cell Biochem. 2022. PMID: 35089527 Review.
Wound healing in diabetes is impaired and delayed and is augmented by diabetic complications. ...In this review, we critically reviewed the pros and cons of experimental models of diabetic wound healing with a focus on type II diabetes rodent models... …
Wound healing in diabetes is impaired and delayed and is augmented by diabetic complications. ...In this review, we critically review …
In Silico Approaches to Identify Polyphenol Compounds as α-Glucosidase and α-Amylase Inhibitors against Type-II Diabetes.
Riyaphan J, Pham DC, Leong MK, Weng CF. Riyaphan J, et al. Biomolecules. 2021 Dec 14;11(12):1877. doi: 10.3390/biom11121877. Biomolecules. 2021. PMID: 34944521 Free PMC article. Review.
Type-II diabetes mellitus (T2DM) results from a combination of genetic and lifestyle factors, and the prevalence of T2DM is increasing worldwide. Clinically, both alpha-glucosidase and alpha-amylase enzymes inhibitors can suppress peaks of postprandial
Type-II diabetes mellitus (T2DM) results from a combination of genetic and lifestyle factors, and the prevalence
Glucokinase as an emerging anti-diabetes target and recent progress in the development of its agonists.
Ren Y, Li L, Wan L, Huang Y, Cao S. Ren Y, et al. J Enzyme Inhib Med Chem. 2022 Dec;37(1):606-615. doi: 10.1080/14756366.2021.2025362. J Enzyme Inhib Med Chem. 2022. PMID: 35067153 Free PMC article. Review.
Type 2 diabetes mellitus is a metabolic disorder with complicated pathogenesis, and mono-target therapy often fails to effectively manage the levels of blood glucose. ...Activation of GK induces glucose metabolism and reduces glucose levels for the tre
Type 2 diabetes mellitus is a metabolic disorder with complicated pathogenesis, and mono-target therapy often fa
The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms.
Massimino E, Izzo A, Riccardi G, Della Pepa G. Massimino E, et al. Cells. 2021 Aug 1;10(8):1958. doi: 10.3390/cells10081958. Cells. 2021. PMID: 34440727 Free PMC article. Review.
Mounting evidence suggests that the prevalence of sarcopenia is higher in patients with type 2 diabetes mellitus (T2DM), and different mechanisms may be responsible for this association such as impaired insulin sensitivity, chronic hyperglycemia, advan …
Mounting evidence suggests that the prevalence of sarcopenia is higher in patients with type 2 diabetes mellitus
32,321 results
You have reached the last available page of results. Please see the User Guide for more information.